Healthcare, Life Sciences and Pharmaceuticals · Published Aug 2026
Patient Lateral Transfer Devices Market
The global Patient Lateral Transfer Devices market was valued at USD 10,000 Million in 2025 and is projected to reach USD 18,771.37 Million by 2035, expanding at a CAGR of 6.5% over the forecast period. Growth is driven by rising healthcare facility investments and increasing patient mobility needs. Regulatory emphasis on patient safety and ergonomic handling continues to shape product development.
The market remains fragmented with opportunities for innovation in reusable and disposable solutions.
Market size
Growth trajectory through 2035
Patient Lateral Transfer Devices Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
2025 Regulatory approvals for reusable lateral transfer devices
- In Q2 2025, the FDA granted 510(k) clearance to three new reusable slide sheet systems designed for high-load patient transfers, addressing infection control concerns in long-term care facilities.
-
Development 02 Integration of IoT sensors in air-assisted mattresses
- Major manufacturers launched smart air-assisted transfer mattresses with embedded pressure sensors to monitor patient positioning and reduce shear injuries, with pilot programs underway in European hospitals.
-
2026 Partnerships for sustainable disposable alternatives
- Leading suppliers announced collaborations with biodegradable material providers to develop disposable lateral transfer accessories with reduced environmental impact, targeting launch in 2026.
Emerging opportunities added
- Sustainable reusable solutions Demand for eco-friendly medical devices creates openings for durable lateral transfer systems with lower lifecycle costs.
- Integration with smart healthcare systems Connected devices that track patient movement and staff ergonomics can capture premium pricing in advanced markets.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $10.00 Bn
- CAGR
- 6.50%
- Expansion
- 1.9×
Market shape
top segment · 46.7% share
- Leading region
- North America
- Top-5 concentration
- Low · ~35%
Forces at play
▲ top tailwind
- ▼ headwind
- Cost sensitivity in disposable segments
- Named players
- 21 profiled
- Growth peak
- 2027–2031
Latest development
Regulatory approvals for reusable lateral transfer devices: In Q2 2025, the FDA granted 510(k) clearance to three new reusable slide sheet systems designed for high-load patient transfers, addressing infection control concerns in long-term care facilities
+2 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 80-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Patient Lateral Transfer Devices Market today ($10.00 Bn base), and how fast will it grow at 6.5% CAGR through 2035?
- Which of Air-assisted Transfer Mattresses, Slide Sheets, Lateral Transfer Accessories holds the largest share, and how do the growth rates diverge?
- How is demand distributed across Hospitals, Ambulatory Surgical Centers, Nursing Homes applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America compare on market share, growth rate, and regulatory posture?
- Where do GSK plc, Pfizer Inc, Johnson & Johnson and 18 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Increasing hospital investments) and top restraints (led by Cost sensitivity in disposable segments), with quantified CAGR impact?
- What regulatory shifts and 3 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Increasing hospital investments Expansion of healthcare facilities globally is driving demand for lateral transfer devices to support patient mobility workflows.
- Regulatory focus on patient safety Mandates for ergonomic patient handling reduce injury risks for staff and patients, accelerating adoption of certified transfer devices.
- Growth in ambulatory surgical centers Rising outpatient procedures increase the need for efficient lateral transfer solutions in non-hospital settings.
Restraints
Holding it back
- Cost sensitivity in disposable segments Budget constraints in emerging markets limit adoption of single-use lateral transfer products.
- Limited awareness in low-resource regions Underdeveloped healthcare infrastructure and lack of training impede market penetration in certain geographies.
- Competition from manual transfer methods In some facilities, traditional techniques persist due to lower upfront costs despite higher long-term risks.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Increasing hospital investments | +2.9% | Global | 2025–2035 |
| Regulatory focus on patient safety | +1.8% | Global | 2025–2035 |
| Growth in ambulatory surgical centers | +1.4% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Cost sensitivity in disposable segments | −1.2% | Global | 2025–2029 |
| Limited awareness in low-resource regions | −0.8% | Global | 2025–2029 |
| Competition from manual transfer methods | −0.6% | Global | 2025–2029 |
Total 6 Air-assisted Tra 50% Slide Sheets 33% Lateral Transfer 17% The market is segmented by product type, usage, end user, and region. Product categories include air-assisted transfer mattresses, slide sheets, and lateral transfer accessories.
Revenue share by type · 2025 base year
% OF $10.00 BN PATIENT LATERAL TRANSFER DEVICES MARKET · 3 TYPES COVERED
Each slice = that type's share of the total $10.00 Bn Patient Lateral Transfer Devices Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Air-assisted Transfer Mattresses
-
Slide Sheets
-
Lateral Transfer Accessories
By application
-
Hospitals
-
Ambulatory Surgical Centers
-
Nursing Homes
-
Rehabilitation Centers
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $10.00 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~38.4% in 2025. High healthcare spending and strong regulatory frameworks support adoption of advanced lateral transfer devices
Per-region detail
-
North America
High healthcare spending and strong regulatory frameworks support adoption of advanced lateral transfer devices
-
Europe
Aging population and emphasis on patient safety drive steady market growth across hospitals and long-term care facilities
-
Asia-Pacific
Rapid hospital expansion and increasing medical tourism create significant growth opportunities for transfer device manufacturers
-
Latin America
Healthcare infrastructure development and government initiatives to improve patient care are expanding market reach
-
Middle East & Africa
Rising healthcare investments and partnerships with international providers are accelerating device adoption
Competitive landscape
Who's competing, and how
The market is Low concentration. 21 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The market exhibits moderate fragmentation with a mix of global medical technology firms and specialized suppliers. Innovation and regulatory compliance are key differentiators.
Concentration snapshot
Top 5 players control 35.0% of the market
Aggregate 2025 share of the top 5 named players (real market share data). Individual company shares in the full report.
Competitive tiers
Players are bucketed by base-year market share: Leaders ≥ 7%, Challengers 3–7%, Emerging < 3%. Full tier rationale + revenue estimates in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Johnson & Johnson · Merck · Novartis
Tier 2 · Challengers
4companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Roche · AbbVie · Eli Lilly · AstraZeneca
Tier 3 · Emerging
14companies
Niche or early-stage, differentiated technology or early-mover positioning.
GSK plc · Pfizer Inc · Roche Holding AG · Novartis AG · Merck & Co., Inc
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
GSK plc
Rank 01Share est. ~13%Revenue $38B FYHQ UK · London -
Pfizer Inc
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Johnson & Johnson
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Roche Holding AG
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Novartis AG
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Merck & Co., Inc
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
AbbVie Inc
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
Eli Lilly and Company
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 13 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA CDER/CBER approves new drugs and biologics; typical NDA review 10 months (standard), 6 months (priority). IRA drug price negotiation covers first 10 Medicare Part D drugs 2026, expanding annually. CMS coverage decisions gate market access. State-level PBM reform + 340B changes reshape distribution.
-
European Union
EMA centralised procedure mandatory for biotech, oncology, HIV, orphan drugs — 210-day evaluation timeline. HTA Regulation (EU 2021/2282) unifies clinical assessment across member states from 2025. Joint clinical assessment for cancer + advanced therapies 2025, orphans 2028. GDPR + national health data laws govern secondary use of clinical data.
-
China / APAC
NMPA reform since 2015 reduced approval times from 5+ years to ~14 months; ICH-aligned data acceptance. Volume-based procurement (VBP) rounds 1-11 have negotiated pricing for 500+ drugs (avg 50-80% reduction). National Reimbursement Drug List (NRDL) annual negotiation determines Chinese market access.
-
Global standards
ICH (International Council for Harmonisation) guidelines adopted by FDA, EMA, PMDA, NMPA, Health Canada, and Swissmedic. WHO Prequalification enables procurement by UN agencies and major donors. USP, EP, JP pharmacopoeia standards govern drug quality worldwide. GxP quality standards (GCP, GMP, GLP, GVP) universal.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
• What is the worth of global Patient Lateral transfer market?
The Patient Lateral transfer market size had crossed USD 0.28 Billion in 2020 and will observe a CAGR of more than 9% up to 2029 driven by the increasing demand for patient lateral transfer devices which aid in efficient patient transfer by improving postures while moving partially or wholly dependent patients. -
• What is the size of the North America patient lateral transfer industry?
North America held more than 32% of the patient lateral transfer market revenue share in 2020 as majority of hospitals in North America have started using various patient lateral transfer products, making it easy to transfer patients. -
• What are the upcoming trends of patient lateral transfer market, globally?
The upcoming trends in patient lateral transfer market are that the ageing population and rising prevalence of chronic illnesses have resulted in patients staying in hospitals for longer periods, which may increase demand for patient lateral transfer devices over the forecast period, as they assist patients in transferring from their beds for any urgent medical purposes. -
• What is the CAGR of patient lateral transfer market?
The global patient lateral transfer market registered a CAGR of 9% from 2022 to 2029. The air assisted lateral transfer mattresses segment was the highest revenue contributor to the market, with 0.10 billion in 2020, and is estimated to reach 0.26 billion by 2029, with a CAGR of 6%. -
• Which are the top companies to hold the market share in patient lateral transfer market?
Key players profiled in the report include Stryker, Hill-Rom Holdings, Inc., Arjo, Handicare, Etac Group, Sizewise, McAuley Medical, Inc., Medline Industries Inc., Samarit Medical AG, Blue Chip Medical, Inc., Haines Medical Australia, Scan Medical Co Inc., WY’ East Medical Company, GBUK Banana, Johnson & Johnson Services, Inc., Arthrex Inc. -
• What is the leading application of patient lateral transfer market?
Leading application of patient lateral transfer market are hospitals. Because of growing number of persons with mobility disabilities and increasing senior population, as well as rising number of hospital admissions, hospitals have dominated overall demand for total patient lateral transfer devices. -
• Which is the largest regional market for patient lateral transfer market?
North America is likely to be a major revenue-generating region for patient positioning devices. With rise in the number of caregivers suffering from Musculoskeletal Disorders (MSDs), majority of hospitals in North America have started using various patient lateral transfer products, making it easy to transfer patients.
The Patient Lateral Transfer Devices Market is projected to reach $18.77 Bn by 2035, up from $10.00 Bn in 2025 — a 6.50% CAGR equating to roughly 1.9× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.